Delivery Order SPE2DB24D2205-SPE2DB25FEGLR
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,069.03 to AmerisourceBergen Drug Corp for the supply of Lyrica 225 mg capsules (90-count units) under a firm fixed-price contract type. The award, issued on August 26, 2025, with an ultimate completion date of August 27, 2025, represents a non-set-aside competitive procurement. Performance will be executed from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,773.39 to AmerisourceBergen Drug Corp for the supply of Lyrica 150 mg capsules (90-count units). This firm fixed price contract, awarded on September 4, 2025, with an ultimate completion date of September 5, 2025, represents a child order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition with no set-aside designation. Performance will be executed...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Lyrica 200 mg capsules (90-count units) under a firm fixed price contract with a ceiling value of $1,775.64. The order is scheduled for completion by August 25, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This delivery order is a non-set-aside competitive award, reflecting AmerisourceBergen's demonstrated capability to meet...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,580.34 to AmerisourceBergen Drug Corp for the supply of Lyrica 100 mg capsules (90-count units). This firm fixed price, competitively awarded contract was issued on September 11, 2025, with an ultimate completion date of September 12, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting open competition among qualified pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lyrica 100 mg capsules (90-count) with a ceiling value of $3,550.74. This firm fixed-price contract, awarded on August 26, 2025, with an ultimate completion date of August 27, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,851.66 to AmerisourceBergen Drug Corp for the supply of Lyrica 200 mg capsules (90-count units) on July 24, 2025, with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a $3,551.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lyrica 200 mg capsules (90-count units) on August 22, 2025, with an ultimate completion date of August 25, 2025. This non-competitive delivery order represents a routine pharmaceutical procurement under the company's existing contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Lyrica 100 mg capsules (quantity 90) with a ceiling value of $11,191.13. This firm fixed price delivery order, which represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), was competitively awarded with no set-aside designation. The ultimate completion date is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lyrica 225 mg capsules (90-count) with a ceiling value of $1,218.19. This non-competitive, firm fixed-price delivery order was awarded on August 25, 2025, with an ultimate completion date of August 26, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,887.22 to AmerisourceBergen Drug Corp for the supply of Lyrica 225 mg capsules (90-count units). This firm fixed-price, non-set-aside contract was competitively awarded on September 9, 2025, with an ultimate completion date of September 10, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEGLRDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lyrica 225 mg capsules (90-count units) under a firm fixed-price contract with a ceiling value of $2,383.48. The award, issued on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a non-set-aside, competitively awarded delivery order. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs, particularly supporting military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and running through December 2026. This comprehensive prime contract vehicle enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. Lyrica (pregabalin) is a neurological treatment used in military healthcare systems, and this delivery order fulfills a specific requirement within the broader pharmaceutical supply framework managed by the DLA's Medical Supply Chain for the Defense Health Agency and related government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 8/19/25 |